Should You Hold Chemed Stock in Your Portfolio Now?
CHE's VITAS growth and Roto-Rooter improvements support its outlook, but inflation, tariffs and competitive pressures remain key risks.
Chemed Corporation (CHE) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript
Chemed Corporation (CHE) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript
Chemtrade Logistics Income Fund (CHE.UN:CA) Q1 2026 Earnings Call Prepared Remarks Transcript
Chemtrade Logistics Income Fund (CHE.UN:CA) Q1 2026 Earnings Call Prepared Remarks Transcript
Chemed Corporation (CHE) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Chemed Corporation (CHE) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Chemtrade Logistics Income Fund (CHE.UN:CA) Q1 2026 Earnings Call Transcript
Chemtrade Logistics Income Fund (CHE.UN:CA) Q1 2026 Earnings Call Transcript
CHE Stock Up Following Q1 Earnings & Revenue Beat, Margins Down
Chemed stock jumps after Q1 earnings and revenues beat estimates despite margin contraction and mixed segment performance across VITAS and Roto-Rooter.
Abacus FCF Advisors LLC Acquires New Holdings in Chemed Corporation $CHE
Abacus FCF Advisors LLC bought a new position in shares of Chemed Corporation (NYSE: CHE) during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 13,871 shares of the company's stock, valued at approximately $5,935,000. Abacus FCF Advisors LLC owned 0.10% of Chemed at
Chemed Corporation (CHE) Q1 2026 Earnings Call Transcript
Chemed Corporation (CHE) Q1 2026 Earnings Call Transcript
Chemed (CHE) Beats Q1 Earnings and Revenue Estimates
Chemed (CHE) came out with quarterly earnings of $5.65 per share, beating the Zacks Consensus Estimate of $5.17 per share. This compares to earnings of $5.63 per share a year ago.
Evergreen Capital Management LLC Trims Position in Chemed Corporation $CHE
Evergreen Capital Management LLC lowered its position in shares of Chemed Corporation (NYSE: CHE) by 19.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 16,244 shares of the company's stock after selling 4,018 shares during the quarter. Evergreen Capital Management
Chemed Corp (CHE) Stock Down 3.1% -- Now Undervalued? GF Score: 77/100
On April 21, 2026, Chemed Corp (CHE) shares fell 3.1% to $373.79, continuing a downward trend with a year-to-date loss of 12.5%. The stock has traded between a
Analysts Estimate Chemed (CHE) to Report a Decline in Earnings: What to Look Out for
Chemed (CHE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
